More magazine: “My Life, My Day”
November 2003
Featured: Nancy Connell, PhD,
New Jersey Medical School

A day in the life of the director of UMDNJ’s Center for BioDefense.

WABC-TV (New York)
Good Morning America
Wednesday, October 2, 2003
Featured: Woosik Chung, MD,
New Jersey Medical School alumnus ’03

Twenty-four years after his hands were severed in an accident, and then re-attached by his surgeon-father, Chung is a resident in orthopedic surgery. He was interviewed by Diane Sawyer.

Associated Press:
“FDA Advisers Recommend Lifting
Ban on Silicone Breast Implants”
Thursday, October 16, 2003
Featured: Thomas Whalen, MD,
Robert Wood Johnson Medical School

An FDA advisory panel recommends lifting the ban on silicone breast implants. Whalen, who served as chair of the panel, disagrees with its conclusion. Carried in the International Herald Tribune, Paris, France; Philadelphia Inquirer; Daily Record, Baltimore; Star-Ledger; Maui (Hawaii) News.

PBS, The NewsHour with Jim Lehrer
Thursday, November 6, 2003
Featured: James Oleske, MD,
and Arlene Bardeguez, MD,
New Jersey Medical School

The topic discussed was maternal-fetal transmission of HIV. NJMS was the pilot site for a study in 1992 testing a new protocol in which pregnant women received AZT during the birthing process. After more than a decade of refining the procedure, transmission is down to 2 percent.

Philippine Daily Enquirer: “TB Stories”
Sunday, November 9, 2003
Featured: Lee Reichman, MD,
New Jersey Medical School

Even though TB is still endemic in the Philippines, efforts to curb its spread are poorly funded. Reichman speaks out for the need for continued vigilance and funding.

WABC-TV (New York), The Evening News
Tuesday, November 18, 2003
Featured: Jill Brooks, MD,
Robert Wood Johnson Medical School

An expert on concussions resulting from competitive sports, Brooks commented on a study published in the Journal of the American Medical Association about the effects of concussions on collegiate football players.

CBS News.com and CNN.com from an AP story: “Study Finds Three-drug AIDS Combo Superior”
Thursday, December 11, 2003
Featured: Patricia C. Kloser, MD,
New Jersey Medical School

The New England Journal of Medicine published a study that found that a three drug cocktail of efavirenz, lamivudine and zidovudine (AZT) is superior for treating new HIV-infected patients. Kloser, a specialist in treating HIV-infected women, says she has had “fantastic success” with this therapy.

The New York Times:
“Cancer Prevention Is Big Seller,
But Medical Experts Are Divided”
Sunday, January 11, 2004
Featured: Michael Gallo, MD,
Robert Wood Johnson Medical School

The value of cancer prevention programs is questionable, according to specialists. Gallo states that people often exaggerate their own cancer risk and have inflated expectations of what science can do to protect them.

Associated Press:
“Drug Boosts Odds After Heart Stops”
Thursday, January 8, 2004
Featured: Muhamed Saric, MD, University Hospital and New Jersey Medical School

The cardiologist commented on a study published in The New England Journal of Medicine that showed vasopressin to be more effective than epinephrine in saving the lives of those in cardiac arrest. Carried in 30 newspapers nationwide, including the San Francisco Chronicle, St. Louis Post-Dispatch, Seattle Post-Intelligencer and Fort Lauderdale Sun-Times.

The New York Times:
“New Jersey Forges Ahead on Stem Cells”
Saturday, February 21, 2004
Featured: Ira B. Black, MD, Robert Wood Johnson Medical School

Gov. James McGreevey plans to make New Jersey the first state to finance research on human embryonic stem cells. Black says this will vault New Jersey into a world leadership position.

NJ 101.5 FM Radio (Trenton) - the news
Monday, January 5, 2004
Featured: Norman Lasser, MD, New Jersey Medical School

The preventive cardiology expert discussed adolescent obesity.

The Star-Ledger:
“Everlasting Love”
Tuesday, February 10, 2004
Featured: Terrie Ginsberg, DO, School of Osteopathic Medicine

Geriatricians and sex therapists discuss how older adults can maintain an active, fulfilling sex life.

The New York Times:
“The Battle for a
Needle Exchange Program”
Sunday, January 11, 2004
Featured: Robert L. Johnson, MD, New Jersey Medical School and University Hospital

The adolescent medicine specialist, who works with HIV-infected teens, stated that transmission of HIV cannot be reduced in the U.S. unless the issue of IV drug abuse is addressed.

The Star-Ledger:
“The new plague: How killer germs
havedefeated our last antibiotic”
Wednesday, December 10, 2003
Featured: Gil Diamond, PhD,
New Jersey Dental School

In a five part series about the growing virulence of bacteria and the waning effectiveness of antibiotics, Diamond explains that his research focuses on understanding if the action of animal peptides can demonstrate how to boost the human immune system.

The Star-Ledger:
“Making a Pitch for Organ Donors —
An All-star Team of Black Surgeons
Looks to Help Transplant Patients”
Saturday, February 28, 2004
Featured: Dorian Wilson, MD,
University Hospital and New Jersey Medical School;
David Kountz, MD,
Robert Wood Johnson Medical School

Eighteen of the country’s 19 African American transplant surgeons gathered on UMDNJ’s Newark campus to encourage organ donation and inspire medical students to consider this field.

WWOR-TV (Secaucus)
Monday, December 15, 2003
Featured: Robert D. Fechtner, MD,
New Jersey Medical School

The ophthalmologic surgeon performed cataract surgery on health reporter Dr. Frank Field on camera.

The New York Times:
“Entering a Brave New World, Warily”
Sunday, January 18, 2004
Featured: Ira B. Black, MD, Robert Wood Johnson Medical School

The stem cell researcher describes the potential of all stem cell research as threefold: to revive damaged and dead cells; act as vehicle cells in introducing gene therapy; and rally the human body’s own existing stem cells.

Home News Tribune:
“FDA OKs Drug for Itchy Skin”
Wednesday, October 29, 2003
Featured: Alice Gottlieb, MD, PhD,
Robert Wood Johnson Medical School

The FDA approved Raptiva, which blocks the activation of T-cells in the immune system that cause psoriasis to develop. Gottlieb, one of the first researchers to describe psoriasis as an immune disease in the 1980s, headed up the lead site for the earliest studies of human use of Raptiva.